Seryl-tRNA Synthetase (SARS) Peptid
SARS
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Seryl-tRNA Synthetase (SARS) Produkte
- Seryl-tRNA Synthetase (SARS)
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SARS antibody (Catalog #: ARP40655_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Seryl-tRNA Synthetase (SARS)
- Synonyme
- SERRS Peptide, SERS Peptide, Sars1 Peptide, Strs Peptide, serRS Peptide, SerRS Peptide, wu:fk51f08 Peptide, zgc:92152 Peptide, seryl-tRNA synthetase Peptide, seryl-aminoacyl-tRNA synthetase Peptide, SARS Peptide, Sars Peptide, sars Peptide
- Hintergrund
-
SARS belongs to the class II amino-acyl tRNA family. The enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts.This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts.
Alias Symbols: SERS, SERRS
Protein Interaction Partner: JUN,SIRT2,TRNAS2
Protein Size: 514 - Molekulargewicht
- 57 kDa
- Gen-ID
- 6301
- NCBI Accession
- NM_006513, NP_006504
- UniProt
- Q5T5C8
-
Sie sind hier:
